Studies have shown that the activation of inflammasomes in the NAFLD liver leads to the expression of pro-inflammatory cytokines such as interleukin-1 beta (IL-1β) and interleukin-18 (IL-18) and promotes cell apoptosis by activating caspase-1 (48, 49). This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.